Observational studyThe journal of headache and pain2023

Galcanezumab effects on incidence of headache after occurrence of triggers, premonitory symptoms, and aura in responders, non-responders, super-responders, and super non-responders.

Sait Ashina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.